Ausdal Financial Partners’s Oncolytics Biotech ONCY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.28K | Sell |
12,000
-2,400
| -17% | -$1.86K | ﹤0.01% | 688 |
|
|
2025
Q1 | $7.92K | Sell |
14,400
-600
| -4% | -$330 | ﹤0.01% | 641 |
|
|
2024
Q4 | $13.7K | Buy |
15,000
+1,000
| +7% | +$914 | ﹤0.01% | 564 |
|
|
2024
Q3 | $12.2K | Sell |
14,000
-7,000
| -33% | -$6.1K | ﹤0.01% | 511 |
|
|
2024
Q2 | $20.8K | Sell |
21,000
-5,000
| -19% | -$4.95K | ﹤0.01% | 492 |
|
|
2024
Q1 | $27.6K | Sell |
26,000
-4,000
| -13% | -$4.24K | ﹤0.01% | 461 |
|
|
2023
Q4 | $40.5K | Buy |
30,000
+10,000
| +50% | +$13.5K | 0.01% | 449 |
|
|
2023
Q3 | $43.6K | Buy |
+20,000
| New | +$43.6K | 0.01% | 424 |
|